|
|
|
Volumn 97, Issue , 2010, Pages 17-28
|
|
Renal cell carcinoma management and therapies in 2010;Prise en charge et traitements médicaux des cancers du rein en 2010.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
DRUG DERIVATIVE;
EVEROLIMUS;
INDOLE DERIVATIVE;
INTERFERON;
INTERLEUKIN 2;
MAMMALIAN TARGET OF RAPAMYCIN;
MONOCLONAL ANTIBODY;
PROTEIN SERINE THREONINE KINASE;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RAPAMYCIN;
SIGNAL PEPTIDE;
SORAFENIB;
SUNITINIB;
TEMSIROLIMUS;
VASCULOTROPIN A;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METABOLISM;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
NEPHRECTOMY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
HUMANS;
INDOLES;
INTERFERONS;
INTERLEUKIN-2;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
KIDNEY NEOPLASMS;
METABOLIC NETWORKS AND PATHWAYS;
NEPHRECTOMY;
PROTEIN-SERINE-THREONINE KINASES;
PYRIDINES;
PYRROLES;
SIROLIMUS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 77952526266
PISSN: None
EISSN: 17696917
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
